Promosyon programı VBI Vaccines Inc.
Gelişmiş program
Basit grafik
Şirket hakkında VBI Vaccines Inc.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. daha fazla ayrıntı| IPO date | 1995-08-18 |
|---|---|
| ISIN | CA91822J1030 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 0.25 |
| Сайт | https://www.vbivaccines.com |
| Цена ао | 0.0282 |
| Günlük fiyat değişimi: | 0% (0.0282) |
|---|---|
| Haftalık fiyat değişimi: | 0% (0.0282) |
| Aylık fiyat değişimi: | 0% (0.0282) |
| 3 ayda fiyat değişimi: | 0% (0.0282) |
| Altı ayda fiyat değişimi: | 0% (0.0282) |
| Yıllık fiyat değişimi: | -95.01% (0.565) |
| 3 yılda fiyat değişimi: | -97.99% (1.4) |
| 5 yılda fiyat değişimi: | -98.07% (1.46) |
| 10 yılda fiyat değişimi: | 0% (0.0282) |
| Yılbaşından bu yana fiyat değişimi: | 0% (0.0282) |
|
|
Hafife alma
|
Yeterlik
|
|||||||||||||||||||||||||||||||||||||
Temettüler
|
Görev
|
Büyüme dürtüsü
|
|||||||||||||||||||||||||||||||||||||
| Kurumlar | Hacim | Paylaşmak, % |
|---|---|---|
| Perceptive Advisors LLC | 1381355 | 5.83 |
| Alyeska Investment Group, L.P. | 696736 | 2.94 |
| Geode Capital Management, LLC | 138729 | 0.59 |
| Blackrock Inc. | 111960 | 0.47 |
| Cambridge Investment Research Advisors Inc. | 93556 | 0.39 |
| Millennium Management LLC | 71422 | 0.3 |
| Vanguard Group Inc | 64522 | 0.27 |
| General American Investors Company Inc | 62583 | 0.26 |
| Morgan Stanley | 34973 | 0.15 |
| Northern Trust Corporation | 32992 | 0.14 |
| Süpervizör | İş unvanı | Ödeme | Doğum yılı |
|---|---|---|---|
| Mr. Jeffery R. Baxter FCMA | President, CEO & Director | 908.06k | 1961 (64 yıl) |
| Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. | Chief Medical Officer | 544.52k | 1955 (70 yıllar) |
| Ms. Nell Beattie | CFO, Head of Corporate Development & Director | N/A | 1988 (37 yıllar) |
| Ms. Athena Kartsaklis | Senior VP of Finance, Chief Compliance Officer & Principal Financial Officer | N/A | 1965 (60 yıllar) |
| Mr. Avi Mazaltov | Global Head of Manufacturing & GM of SciVac | N/A | 1962 (63 yıl) |
| Mr. Misha Nossov | Senior VP of Global Commercial Supply Strategy & Head of Europe | N/A | |
| Mr. John Robert Dillman | Chief Commercial Officer | N/A | 1968 (57 yıllar) |
| Dr. David Evander Anderson Ph.D. | Chief Scientific Officer | 1970 (55 yıllar) | |
| Ms. Nicole Anderson | Director of Corporate Communications & Investor Relations | ||
| Mr. T. Adam Buckley B.Sc., MBA | Senior Vice President of Business Development | 1976 (49 yıllar) |
Adres: United States, Cambridge. MA, 160 Second Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.vbivaccines.com
Web sitesi: https://www.vbivaccines.com
